1. Home
  2. BBIO vs FND Comparison

BBIO vs FND Comparison

Compare BBIO & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • FND
  • Stock Information
  • Founded
  • BBIO 2015
  • FND 2000
  • Country
  • BBIO United States
  • FND United States
  • Employees
  • BBIO N/A
  • FND N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • FND RETAIL: Building Materials
  • Sector
  • BBIO Health Care
  • FND Consumer Discretionary
  • Exchange
  • BBIO Nasdaq
  • FND Nasdaq
  • Market Cap
  • BBIO 8.8B
  • FND 8.6B
  • IPO Year
  • BBIO 2019
  • FND 2017
  • Fundamental
  • Price
  • BBIO $49.08
  • FND $88.00
  • Analyst Decision
  • BBIO Strong Buy
  • FND Hold
  • Analyst Count
  • BBIO 16
  • FND 17
  • Target Price
  • BBIO $61.69
  • FND $91.00
  • AVG Volume (30 Days)
  • BBIO 2.9M
  • FND 2.3M
  • Earning Date
  • BBIO 08-05-2025
  • FND 07-31-2025
  • Dividend Yield
  • BBIO N/A
  • FND N/A
  • EPS Growth
  • BBIO N/A
  • FND N/A
  • EPS
  • BBIO N/A
  • FND 1.94
  • Revenue
  • BBIO $235,812,000.00
  • FND $4,600,232,000.00
  • Revenue This Year
  • BBIO $106.33
  • FND $7.01
  • Revenue Next Year
  • BBIO $54.30
  • FND $10.30
  • P/E Ratio
  • BBIO N/A
  • FND $45.37
  • Revenue Growth
  • BBIO 7.62
  • FND 4.88
  • 52 Week Low
  • BBIO $21.72
  • FND $66.01
  • 52 Week High
  • BBIO $51.86
  • FND $124.68
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 55.76
  • FND 60.86
  • Support Level
  • BBIO $48.03
  • FND $79.77
  • Resistance Level
  • BBIO $51.86
  • FND $85.87
  • Average True Range (ATR)
  • BBIO 1.95
  • FND 3.31
  • MACD
  • BBIO -0.08
  • FND 0.34
  • Stochastic Oscillator
  • BBIO 71.55
  • FND 93.86

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

Share on Social Networks: